![](https://etimg.etb2bimg.com/thumb/msid-111978925,imgsize-44234,width-1200,height=765,overlay-ethealth/pharma/pharma-industry/us-drug-industry-middlemen-defend-business-model-amid-accusations-of-raising-patient-costs.jpg)
US drug industry middlemen defend business model amid accusations of raising patient costs
By Amina Niasse and Bhanvi Satija London: U.S. pharmaceutical industry middlemen defended their role in the healthcare system during a Congressional hearing on Tuesday after committee members accused them of pushing patients toward expensive treatments …